Price: $21.90 - $19.80
(as of Apr 29, 2025 18:31:58 UTC – Details)
From the brand
NEW LAUNCH
BEST SELLERS
Package Dimensions ā : ā 4.21 x 1.85 x 1.73 inches; 4.97 ounces
Manufacturer ā : ā Medicube
ASIN ā : ā B0DVSNQ37F
Country of Origin ā : ā Korea, Republic of
All-in-One 72-Hour Glow Serum ā Uneven skin tone, hydration, and skin texture care with 10-layer hyaluronic acid, Panthenol, and Betaine. *Clinical Trial Tested by the ‘Custis Life Science Research Center.’ / Results may vary depending on individual skin types.
Gentle Vitamin B12 Formula for Daily Use ā Lightweight, low-irritation, and fragrance-free formula. Contains Panthenol and Coral Moss Extract to calm and soothe skin. Suitable for daily use.
5% Tranexamic Acid (TXA) ā Maximum Strength for After Spot Care ā *medicube’s highest TXA concentration for after spot care and enhancing your skincare routine. *The above information pertains only to the characters of the raw materials *Maximum application rate of tranexamic acid according to company skincare standards.
Exclusive medicube Ingredient Blend ā Powered by a unique combination of 5% Tranexamic, 10% Niacinamide, and 2% Arbutin, this serum deeply hydrates, refines skin texture, and leave your skin visibly healthier.
Clinically Proven Results of TXA + Niacinamide 15% Serum: Boosts radiance by 15.6% after just one use and improves skin texture by 7.5% after one week of use. Achieve smooth, glass glow skin with a mild formula. *Clinical Trial Tested by the ‘Custis Life Science Research Center.’ / Results may vary depending on individual skin types.
Customers say
Customers find the serum effective, with one mentioning it worked on their hyperpigmentation. The product receives positive feedback for its hydrating properties, with one customer noting it made their skin instantly feel hydrated.
AI-generated from the text of customer reviews
Disclosure: This post contains affiliate links. If you make a purchase through these links, I may earn a commission at no extra cost to you.
Reviews
There are no reviews yet.